Review: Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?
The ability of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) to lower blood pressure (BP) is well established. ACE inhibitors (ACE-Is) have also been shown to improve the prognosis of a broad range of patients at high cardiovascular risk, including those...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2003-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/jraas.2003.015 |